The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Graves' Ophthalmopathy
Open accessAbstract
A 40-year-old woman in whom Graves' disease was recently diagnosed comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg per day, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms, including redness, tearing, grittiness, photophobia, diplopia at the extremes of gaze, and ocular pain associated with eye movements. She smokes 10 cigarettes per day. How should Graves' ophthalmopathy be managed?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
Mourits, M. P., Prummel, M. F., Wiersinga, W. M., & Koornneef, L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2331047.x · Cited by 1,001
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0666 · Cited by 795
Self-citationRelation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Self-citationManagement of Graves’ Ophthalmopathy: Reality and Perspectives*
Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 677
Self-citationBrent, G. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801880 · Cited by 594
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Eckstein, A. K., Plicht, M., Lax, H., Neuhäuser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J., & Morgenthaler, N. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2813 · Cited by 477
Clinical Features of Graves' Ophthalmopathy in an Incidence Cohort
BARTLEY, G. B., FATOURECHI, V., KADRMAS, E. F., JACOBSEN, S. J., ILSTRUP, D. M., GARRITY, J. A., & GORMAN, C. A. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70276-4 · Cited by 459
Randomized, Single Blind Trial of Intravenous versus Oral Steroid Monotherapy in Graves’ Orbitopathy
Kahaly, G. J., Pitz, S., Hommel, G., & Dittmar, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0148 · Cited by 423
Bartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0315 · Cited by 406
Self-citationPrednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212002 · Cited by 359
McKeag, D., Lane, C., Lazarus, J. H., Baldeschi, L., Boboridis, K., Dickinson, A. J., Hullo, A. I., Kahaly, G., Krassas, G., Marcocci, C., et al. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.094607 · Cited by 335
Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
Prummel, M. F., Berghout, A., Wiersinga, W. M., Mourits, M. P., Koornneef, L., & Blank, L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92001-a · Cited by 332
Terwee, C. B., Gerding, M. N., Dekker, F. W., Prummel, M. F., & Wiersinga, W. M. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.7.773 · Cited by 321
Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A., & Pinchera, A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212001 · Cited by 318
Self-citationMarcocci, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3562 · Cited by 309
_, _., Wiersinga, W. M., Perros, P., Kahaly, G. J., Mourits, M. P., Baldeschi, L., Boboridis, K., Boschi, A., Dickinson, A. J., Kendall-Taylor, P., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02230 · Cited by 302
Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy
Bartalena, L., Marcocci, C., Tanda, M. L., Manetti, L., Dell'Unto, E., Bartolomei, M. P., Nardi, M., Martino, E., & Pinchera, A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00010 · Cited by 295
Self-citationRadiotherapy for Graves' orbitopathy: randomised placebo-controlled study
Mourits, M. P., van Kempen-Harteveld, M. L., García, M. B. G., Koppeschaar, H. P., Tick, L., & Terwee, C. B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02165-6 · Cited by 291
Bartalena, L., Marcocci, C., Chiovato, L., Laddaga, M., Lepri, G., Andreani, D., Cavallacci, G., Baschieri, L., & Pinchera, A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1139 · Cited by 272
Self-citationSalvi, M., Vannucchi, G., Campi, I., Currò, N., Dazzi, D., Simonetta, S., Bonara, P., Rossi, S., Sina, C., Guastella, C., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02325 · Cited by 264
Pathophysiology of Graves’ Ophthalmopathy: The Cycle of Disease
Bahn, R. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030010 · Cited by 229
Prummel, M. F., Terwee, C. B., Gerding, M. N., Baldeschi, L., Mourits, M. P., Blank, L., Dekker, F. W., & Wiersinga, W. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030809 · Cited by 228
Pfeilschifter, J., & Ziegler, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8220832.x · Cited by 227
Natural history of thyroid associated ophthalmopathy
Perros, P., Cromble, A. L., & Kendall‐Taylor, P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02597.x · Cited by 219
Wakelkamp, I. M. M. J., Baldeschi, L., Saeed, P., Mourits, M. P., Prummel, M. F., & Wiersinga, W. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02345.x · Cited by 217
The effect of etanercept on Graves' ophthalmopathy: a pilot study
Paridaens, D., van den Bosch, W. A., van der Loos, T. L., Krenning, E. P., & van Hagen, P. M. (2005) · Eye · doi:10.1038/sj.eye.6701768 · Cited by 193
Tallstedt, L., Lundell, G., Blomgren, H., & Bring, J. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300494 · Cited by 171
Marinò, M., Morabito, E., Brunetto, M. R., Bartalena, L., Pinchera, A., & Marocci, C. (2004) · Thyroid · doi:10.1089/105072504774193276 · Cited by 170
Self-citationPerros, P., Kendall-Taylor, P., Neoh, C., Frewin, S., & Dickinson, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0507 · Cited by 156
Moli, R. L., Baldeschi, L., Saeed, P., Regensburg, N. I., Mourits, M. P., & Wiersinga, W. M. (2007) · Thyroid · doi:10.1089/thy.2006.0267 · Cited by 136
Menconi, F., Marinò, M., Pinchera, A., Rocchi, R., Mazzi, B., Nardi, M., Bartalena, L., & Marcocci, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1800 · Cited by 132
Self-citationvan Geest, R. J., Sasim, I. V., Koppeschaar, H. P. F., Kalmann, R., Stravers, S., Bijlsma, W. R., & Mourits, M. P. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0558 · Cited by 127
Fassi, D. E., Nielsen, C. H., Hasselbalch, H. C., & Hegedűs, L. D. (2006) · Thyroid · doi:10.1089/thy.2006.16.709 · Cited by 116
Orbital Radiation for Graves Ophthalmopathy
Bradley, E. A., Gower, E. W., Bradley, D. J., Meyer, D. R., Cahill, K. V., Custer, P. L., Holck, D. E. E., & Woog, J. J. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.028 · Cited by 111
WEISSEL, M., & Hauff, W. (2000) · Thyroid · doi:10.1089/thy.2000.10.521 · Cited by 101
Measuring disease activity to predict therapeutic outcome in Graves’ ophthalmopathy
Terwee, C. B., Prummel, M. F., Gerding, M. N., Kahaly, G. J., Dekker, F. W., & Wiersinga, W. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02186.x · Cited by 85
Preventing Graves' Ophthalmopathy
Wiersinga, W. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380209 · Cited by 81
A questionnaire survey on the management of Graves’ orbitopathy in Europe
_, _., Perros, P., Baldeschi, L., Boboridis, K. G., Dickinson, A. J., Hullo, A., Kahaly, G. J., Kendall-Taylor, P., Krassas, G. E., Lane, C., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02201 · Cited by 76
Bahn, R. S. (2002) · Thyroid · doi:10.1089/105072502753600124 · Cited by 75
Low- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial
Kahaly, G. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.102 · Cited by 60
Early versus Late Orbital Decompression in Graves’ Orbitopathy
Baldeschi, L., Wakelkamp, I. M. M. J., Lindeboom, R., Prummel, M. F., & Wiersinga, W. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.060 · Cited by 55
Jiménez‐Reina, L., Leal‐Cerro, A., García, J. D., García‐Luna, P. P., Astorga, R., & Bernal, G. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210185 · Cited by 55
Novel Immunomodulating Agents for Graves Orbitopathy
Bartalena, L., Lai, A., Compri, E., Marcocci, C., & Tanda, M. L. (2008) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0b013e318179f8a5 · Cited by 29
Self-citation
Cited by
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
Self-citationIntravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
Zang, S., Ponto, K. A., & Kahaly, G. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1962 · Cited by 379
Bartalena, L., Krassas, G. E., Wiersinga, W., Marcocci, C., Salvi, M., Daumerie, C., Bournaud, C., Stahl, M., Sassi, L., Veronesi, G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2389 · Cited by 370
Self-citationEpidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
Bartalena, L., Piantanida, E., Gallo, D., Lai, A., & Tanda, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615993 · Cited by 369
Self-citation
Metadata
- Authors
- Bartalena, L., & Tanda, M. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-03-05
- Volume
- 360
- Issue
- 10
- Pages
- 994-1001
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W188362558
- Cited by
- 336
- References
- 45
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.